Jing Qin

Prevalence of kidney stones in China: an ultrasonography based cross‐sectional study

Guohua Zeng, Zanlin Mai, Shujie Xia et al. · British Journal of Urology · 2017 · 553 citations · Full text

Medicine, Nephrology, Urology +8

A 2-step comprehensive high-dose chemoradiotherapy second-line program for relapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model

Craig H. Moskowitz, Stephen D. Nimer, Andrew D. Zelenetz et al. · Blood · 2001 · 427 citations · Full text

Medicine, Oncology, Radiation Oncology +13

Rituximab and ICE as second-line therapy before autologous stem cell transplantation for relapsed or primary refractory diffuse large B-cell lymphoma

Tarun Kewalramani, Andrew D. Zelenetz, Stephen D. Nimer et al. · Blood · 2004 · 406 citations · Full text

Medicine, Immunology, Pharmacotherapy +12

Risk of Disease Recurrence and Second Neoplasms in Survivors of Childhood Cancer Treated with Growth Hormone: A Report from the Childhood Cancer Survivor Study

Charles A. Sklar, Ann Mertens, Pauline Mitby et al. · The Journal of Clinical Endocrinology & Metabolism · 2002 · 302 citations

Medicine, Oncology, Pediatrics +17

Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin disease

David J. Straus, Carol S. Portlock, Jing Qin et al. · Blood · 2004 · 278 citations · Full text

Medicine, Oncology, Radiation Oncology +15